Novartis, AstraZeneca Cede Seed Business: Two Pharma Pure Plays Created
Executive Summary
The Novartis/AstraZeneca agribusiness spin-off reflects the "limited" synergies between the agricultural and pharmaceutical businesses, the two companies maintained.
You may also be interested in...
Aventis Decision On Ag Business Expected Within 18 Months
Aventis expects to make a decision on carrying forward with its agricultural business component in 2001, Investor Relations Director Arvind Sood said during a July 28 conference call.
Aventis Decision On Ag Business Expected Within 18 Months
Aventis expects to make a decision on carrying forward with its agricultural business component in 2001, Investor Relations Director Arvind Sood said during a July 28 conference call.
Novartis Rx Exec Changes Include U.S. COO Epstein To Oncology Unit Head
Novartis Pharmaceutical U.S. Chief Operating Officer David Epstein will head the Swiss company's new global oncology business unit effective Sept. 1.